Future Medicine Ltd., part of Future Science Group, UK, has announced that its new journal Diabetes Management, launched in January 2011, has been selected for coverage by Chemical Abstracts.
Chemical Abstracts, a division of the American Chemical Society, is an authoritative and comprehensive source for chemical information. CAS databases, including CAS REGISTRYSM, the gold standard for substance information, are curated and quality-controlled by CAS scientists.
Diabetes Management is published on a bi-monthly basis in print and online formats on a rapid publication basis, with articles subject to peer review by three independent assessors. The journal has an international expert authorship and offers commentary and analysis on the advances and current research on the prevention and treatment of diabetes.
Coverage of the journal is overseen by four Associate Editors and an extensive international advisory panel. The four Associate Editors are Denis Daneman, University of Toronto, Canada, Philippe Froguel, Imperial College London, UK, Camillo Ricordi, University of Miami, FL, USA and Jaakko Tuomilehto, University of Helsinki, Finland.
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
